Molly Kerrigan
Patient Science Lead, Patient Safety Data & Analytics AstraZeneca
Seminars
Wednesday 6th May 2026
Ensuring Representative Clinical Trials: Design, Measurement, Action
12:00 pm
- Inclusive Study Design: How do we examine eligibility criteria and embed recruitment strategies to reach intended-use populations?
- Real‑Time Measurement: What metrics help us uncover barriers to participation and how we demonstrate progress?
- Portfolio‑Level Action: How do we translate cross-study trends into action across clinical programs?
